If you take more PsicotricRetard600 mg than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring the tablets of this medication with you.
You can also call the Toxicological Information Service, Tf: 915620420, indicating the medication and the amount taken.
If you forget to take Psicotric Retard 600 mg
If you forget to take a dose, take it as soon as you remember. If it is almost time to take the next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Psicotric Retard 600 mg
If you stop taking PsicotricRetard600 mg abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability.
Your doctor may suggest reducing the dose gradually before interrupting treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
This medication, like all medicines, can cause side effects, although not everyone will experience them.
Very common side effects (may affect more than 1 in 10 people):
·Dizziness (may lead to falls), headache, dry mouth.
·Sensation of drowsiness (which may disappear over time as you continue to take quetiapine), (may lead to falls).
·Withdrawal symptoms (symptoms that occur when you stop taking quetiapine), which include insomnia, nausea, headache, diarrhea, vomiting, dizziness, and irritability. A gradual withdrawal over a period of at least 1 to 2 weeks is recommended.
·Weight gain.
·Abnormal muscle movements. These include difficulty initiating muscle movements, tremor, sensation of restlessness or muscle rigidity without pain.
·Changes in the amount of certain fats (triglycerides and total cholesterol).
Common side effects (may affect up to 1 in 10 people):
·Fast heart rate.
·Feeling like your heart is beating strongly, rapidly, or irregularly.
·Constipation, indigestion.
·Sensation of weakness.
·Swelling of arms or legs.
·Low blood pressure when standing. This may cause dizziness or fainting (may lead to falls).
·Increased blood sugar levels.
·Blurred vision.
·Abnormal dreams and nightmares.
·Feeling hungrier.
·Feeling irritable.
·Speech and language disorder.
·Thoughts of suicide and worsening of depression.
·Shortness of breath.
·Vomiting (mainly in elderly people).
·Fever.
·Changes in the amount of thyroid hormones in the blood.
·Decrease in the number of certain types of blood cells.
·Increases in liver enzymes measured in the blood.
·Increases in prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to:
oBoth in men and women, breast swelling and unexpected milk production.
oIn women, not having a menstrual period or having irregular periods.
Uncommon side effects (may affect up to 1 in 100 people):
·Seizures or convulsions.
·Allergic reactions that may include hives, skin swelling, and swelling around the mouth.
·Unpleasant sensations in the legs (also known as restless leg syndrome).
·Difficulty swallowing.
·Involuntary movements, mainly of the face or tongue.
·Sexual dysfunction.
·Diabetes.
·Prolongation of the QT interval seen on the ECG.
·Difficulty urinating.
·Fainting (may lead to falls).
·Stuffy nose.
·Decrease in the number of red blood cells in the blood.
·Decrease in the amount of sodium in the blood.
. Worsening of pre-existing diabetes.
Rare side effects (may affect up to 1 in 1,000 people):
·A combination of high temperature (fever), sweating, muscle stiffness, feeling very drowsy or dizzy (a condition known as "neuroleptic malignant syndrome").
·Yellowish discoloration of the skin and eyes (jaundice).
·Inflammation of the liver (hepatitis).
·Long-lasting and painful erection (priapism).
·Swelling of the breasts and unexpected milk production (galactorrhea).
·Menstrual disorder.
·Clots in the veins, especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through the blood vessels to the lungs, causing chest pain and difficulty breathing. If you notice any of these symptoms, seek immediate medical attention.
·Walking, talking, eating, or other activities while you are asleep.
·Decrease in body temperature (hypothermia).
·Inflammation of the pancreas.
·A condition (called "metabolic syndrome") where you may experience a combination of 3 or more of the following effects: increase in fat around your abdomen, decrease in "good" cholesterol (HDL-C), increase in a type of fat in the blood called triglycerides, increase in blood pressure, and increase in blood sugar levels.
·A combination of fever, symptoms similar to the flu, sore throat, or any other infection with a very low white blood cell count, a condition known as agranulocytosis.
·Intestinal obstruction.
·Increased creatine phosphokinase in the blood (a substance found in muscles).
Very rare side effects (may affect up to 1 in 10,000 people):
·Severe skin rash, blisters, or red spots on the skin.
·Severe allergic reaction (anaphylaxis) that may cause difficulty breathing or shock.
·Rapid swelling of the skin, usually around the eyes, lips, and throat (angioedema).
·Severe skin condition with blisters on the skin, mouth, eyes, and genitals (Stevens-Johnson syndrome).
·Inappropriate secretion of a hormone that controls urine volume.
·Rhabdomyolysis (rupture of muscle fibers and pain in the muscles).
Not known (frequency cannot be estimated from available data):
·Severe skin rash with irregular red spots (erythema multiforme). See section 2.
. Rapid appearance of skin areas that are red, covered with small pustules (small blisters filled with white/yellow liquid), called Pustulosis Exantemática Generalizada Aguda (PEGA). See section 2.
·Severe allergic reaction with symptoms such as fever and blisters on the skin and peeling of the skin (toxic epidermal necrolysis). See section 2.
This class of medications to which this medication belongs can cause serious heart rhythm problems that can be life-threatening in severe cases.
Some side effects are only observed when a blood test is performed. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increases in liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increases in creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to:
·Both in men and women, breast swelling and unexpected milk production.
·In women, not having a menstrual period or having irregular periods.
Your doctor may ask you to have blood tests from time to time.
Additional side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects (may affect more than 1 in 10 people):
·Increased amount of a hormone called prolactin in the blood. Increases in prolactin hormone may, in rare cases, lead to:
-Both in boys and girls, breast swelling and unexpected milk production.
-In girls, not having a menstrual period or having irregular periods.
·Increased appetite.
·Vomiting.
·Abnormal muscle movements. These include difficulty initiating muscle movements, tremors, sensation of restlessness or muscle rigidity without pain.
·Increased blood pressure.
Common side effects (may affect up to 1 in 10 people):
·Sensation of weakness, fainting (may lead to falls).
·Stuffy nose.
·Feeling irritable.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https//www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Thismedication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE drop-off point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
The active ingredient is quetiapine. The tablets contain600 mg of quetiapine (as quetiapine fumarate).
The other components are:
Tablet core: lactose, copolymer of methacrylic acid – ethyl acrylate (1:1), crystalline maltose type A, magnesium stearate, and talc.
Tablet coating: Copolymer of methacrylic acid – ethyl acrylate (1:1), type A, triethyl citrate.
Appearance of Psicotric Retard 600 mg, and contents of the package
The prolonged-release tablets of 600 mg are white or off-white, oval, biconvex, with “600” engraved on one side.
They are presented in aluminum/PVC/PCTFE blister in a cardboard box.
The package sizes are: 10, 20, 30, 50, 60, and 100 tablets.
Only some package sizes may be commercially available.
Holder of the marketing authorization
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona
Spain
Responsible for manufacturing
Pharmathen International, S.A.
Industrial Park Sapes Rodopi Prefecture Block Nº 5
Rodopi 69300
Greece
or
Pharmathen, S.A.
Dervenakion 6 Str.
Pallini Attiki, 15351
Greece
or
Neuraxpharm Arzneimittel GmbH
Elisabeth-Selbert-Straße 23
40764 Langenfeld
Germany
This medicine is authorized in the member states of the European Economic Area with the following names:
Denmark | Quetamed |
Poland | Questax XR |
Czech Republic | Questax Prolong |
France | Quétiapine Neuraxpharm LP 600 mg, prolonged-release tablet |
Slovakia | Questax XR 600 mg tablets with prolonged release |
Hungary | Questax XR 600 mg retard tablet |
Spain | Psicotric Retard 600 mg prolonged-release tablets |
Germany | Quetiapin-neuraxpharm 600 mg Retardtabletten |
Last review date of this leaflet: June 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.